Ribosomal Protein L10a Inhibitors belong to a specific chemical class of compounds that are characterized by their ability to target and inhibit the activity of the ribosomal protein L10a. Ribosomal proteins are essential components of ribosomes, the cellular organelles responsible for protein synthesis. L10a is a crucial protein that plays a pivotal role in the assembly and functioning of the ribosome. By specifically targeting this protein, the inhibitors disrupt the normal ribosomal machinery, leading to interference with protein synthesis within the cell.
The mechanism of action of Ribosomal Protein L10a Inhibitors involves binding to the L10a protein, which results in the distortion of its native conformation or interaction with other ribosomal components. As a consequence, this disruption affects the ribosomal subunit's stability or alters its ability to catalyze the translation process, thereby impeding protein synthesis. Inhibition of protein synthesis can have significant implications for various cellular functions and processes, as proteins are essential molecules involved in almost every aspect of cellular life. Researchers have been exploring the potential of Ribosomal Protein L10a Inhibitors as valuable tools for understanding ribosomal biology and cellular processes. These inhibitors have been utilized extensively in laboratory settings to study the impact of perturbing protein synthesis and unravel the intricate workings of ribosomes. Furthermore, the study of these inhibitors aids in deciphering the ribosomal assembly process, its dynamic nature, and its role in cellular regulation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
CX-5461 | 1138549-36-6 | sc-507275 | 5 mg | $245.00 | ||
A small molecule inhibitor that specifically targets the ribosomal DNA transcription. | ||||||
BMH-21 | 896705-16-1 | sc-507460 | 10 mg | $165.00 | ||
A synthetic small molecule compound that disrupts ribosomal biogenesis, leading to selective killing of cancer cells. | ||||||
Sangivamycin | 18417-89-5 | sc-204261 sc-204261A sc-204261B sc-204261C sc-204261D sc-204261E | 1 mg 10 mg 25 mg 50 mg 100 mg 250 mg | $333.00 $1348.00 $2611.00 $5212.00 $9894.00 $20298.00 | ||
An anticancer and antiviral agent that interferes with the ribosomal protein synthesis process. | ||||||